Trials / Withdrawn
WithdrawnNCT02539953
Ambulatory Blood Pressure Monitoring in Rivaroxaban Therapy
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- King's College Hospital NHS Trust · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
One in ten patients on rivaroxaban therapy have dizziness and reductions in blood pressure. The investigators intend to monitor the ambulatory blood pressure of such patients in order to assess whether this is a true haemodynamic effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ambulatory blood pressure monitoring | Patients with dizziness on taking rivaroxaban will have ambulatory blood pressure monitoring to assess haemodynamic effects indirectly |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-09-01
- First posted
- 2015-09-03
- Last updated
- 2020-08-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02539953. Inclusion in this directory is not an endorsement.